Procoagulant factors and the risk of myocardial infarction in young women (Q33370819)

26 July 2017

Procoagulant factors and the risk of myocardial infarction in young women (English)

1 reference

26 July 2017

myocardial infarction

1 reference

2

Ale Algra

1 reference

26 July 2017

5

Frits Rosendaal

1 reference

26 July 2017

4

Frans Helmerhorst

1 reference

26 July 2017

1

Bea Tanis

1 reference

PubMed ID

16608503

26 July 2017

Yolanda van der Graaf

series ordinal

3

object named as

Yolanda van der Graaf

1 reference

26 July 2017

11 April 2006

1 reference

European Journal of Haematology

26 July 2017

1 reference

26 July 2017

77

1 reference

26 July 2017

1

1 reference

26 July 2017

67-73

1 reference

Elevated factor VIII levels and the risk of thrombosis

26 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00656.X

Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00656.X

Comparative behaviour of the components of the factor VIII complex in acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00656.X

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00656.X

Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00656.X

Mortality in patients with hemophilia. Changes in a Dutch population from 1986 to 1992 and 1973 to 1986.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00656.X

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00656.X

C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00656.X

The coagulation cascade: initiation, maintenance, and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00656.X

Role of blood coagulation factor XI in downregulation of fibrinolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00656.X

Oral contraceptives and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00656.X

The effect of multi-factorial intervention on plasma von Willebrand factor, soluble E-selectin and tissue factor in diabetes mellitus: implications for atherosclerotic vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00656.X

Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00656.X

Decreased mortality of ischaemic heart disease among carriers of haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00656.X

Inherited factor XI deficiency confers no protection against acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00656.X

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00656.X

An association between atherosclerosis and venous thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00656.X

Myocardial infarction and other vascular diseases in young women. Role of estrogens and other factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00656.X

von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00656.X

Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00656.X

High levels of coagulation factor XI as a risk factor for venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00656.X

Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly. Results from The Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00656.X

Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00656.X

C-reactive protein, cardiovascular risk factors and the association with myocardial infarction in men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00656.X

Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00656.X

Heritability of clotting factors and the revival of the prothrombotic state

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00656.X

Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. French Investigators of the ESSENCE Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00656.X

10.1111/J.1600-0609.2006.00656.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference

PubMed ID

16608503